Deutsch Intern
Rudolf Virchow Center for Integrative and Translational Bioimaging

Press Releases

Below you can find the press releases of the Rudolf Virchow Center:

Dr. Hans Maric has received one of the German Research Foundation's highly prestigious Emmy Noether awards, worth around 1.7 million euros. He will use his biochip technology to study a so far unexplored group of brain proteins and determine their potential to cure so far untreatable mental diseases.


An undesirable effect can occur in super-resolution fluorescence microscopy: photoblueing. A new publication in „Nature Methods“ shows how it can be prevented or made useful for research.


Protein interactions can now be analysed more effectively: A phenomenon called Temperature Related Intensity Change (TRIC) makes it possible to achieve high binding signal intensity even with lowest amounts of sample. Our Maric research group established the method, which can be used to study protein complexes in highly regulated networks such as DNA transcription.


We are inviting applications for a Group Leader (f/m/d) in Chemical Biology. The RVZ appoints group leaders early in their career and provides them with a supportive, collaborative environment and generous work package for their independent position. Significant core funding and limited teaching responsibilities will allow you to embark on a visionary research program.

[Translate to Englisch:]

Artemisinins are pharmaceutical compounds used against the pathogen that causes malaria. However, these substances also have multiple targets in humans which may either be pharmacologically exploited or result in undesirable side effects. Recently, scientists from Würzburg have been able to elucidate one of the underlying molecular mechanisms by showing how these drugs inhibit the vitamin B6 generating enzyme in humans. The results were published in the scientific journal PNAS.


To top